European Companies Search Engine

Tips & Tricks
Our help pages Using the Quick Search and Power Search Overview explain how to use our search engine.

Pfizer Shareholdings Intermediate Sàrl, Luxembourg

Watch
Pfizer Shareholdings Intermediate Sàrl

If you put a company on your watch list, we'll notify you on your email address when there are new publications regarding this company.

This feature is only available to our premium service subscribers.

Learn more about the North Data Premium Service

Premium Service
Unlock Dossier
What is a Dossier?
A dossier provides comprehensive company details as a PDF, together with all underlying original publications and original data in one place.
The download feature is exclusively available for our paid plan. Upgrade your account to access:
Quick Dossier
Entire company details as a PDF
Power Dossier
Entire company details along with all original publications / original data bundled in a ZIP file
Upgrade to unlock all features

Premium plans starting from €/month

Learn more
Learn more
View plans

Name

Pfizer Shareholdings Intermediate Sàrl

Identification

Rcsp
RCS B93997
Lei
549300FZLOEGO2V4Y587
EUID
LURCSL.B93997

Address

51, Avenue John F. Kennedy, 1855 Luxembourg, Luxembourg

Corporate purpose

64.20
Activities of holding companies

Financial performance

Revenue

For this company, Revenue numbers are only available to our premium service subscribers.

Learn more about the North Data Premium Service

History

Persons

Network

Loading network

Legal Structure

Current legal representatives Legal form information Premium
Premium
4Managing Director
1Manager
Upgrade to unlock all features

Premium plans starting from €/month

Learn more View plans
Learn more View plans
Ownership relations Premium + Ownership & Flags add-on
Premium + Ownership & Flags add-on
Shareholders and Investors
2 known active shareholders
Portfolio and Investments
3 known active shareholdings
Upgrade to unlock all features

Premium plans starting from €/month

Learn more View plans
Learn more View plans

Financials

Key Performance Indicators Financial · Mktg & Tech Premium
Premium
Base/share capital
Total assets
Earnings
Earnings CAGR
Revenue
Revenue CAGR
Return on sales
Equity
Equity ratio
Return on equity
Taxes
Tax ratio
Cash on hand
Receivables
Liabilities
Wages and salaries
Upgrade to unlock all features

Premium plans starting from €/month

Learn more View plans
Learn more View plans
Annual report
 
Financial Statements Interactive sheets with CSV/Excel download Premium
Premium
Balance
from 2016 to 2025
Profit & Loss
from 2016 to 2025
Upgrade to unlock all features

Premium plans starting from €/month

Learn more View plans
Learn more View plans

Publications

14 Sept 2026 via Pfizer Trading Polska sp. z o.o.
Shareholding: Pfizer Trading Polska sp. z o.o
23 Jul 2026
Modification which is to take place in the future without a requisition form
13 Jul 2026
Partner: Pfizer Holdings International Luxembourg (Phil) Sàrl · Legal form: Société à responsabilité limitée
17 Jun 2026
Annual report for the year ending 30/11/2025 · Balance sheet for 30/11/2025 · Earnings statement for 30/11/2025
18 Mar 2026
Project of merger / split / transfer of business assets, assets, business division
13 Jan 2026
Managing Director: Maxime Allard · Dismissed: A. Decraene Réginald · Legal form: Société à responsabilité limitée
30 Dec 2025
Project for a European cross-border transformation
1 Jul 2025
Annual report for the year ending 30/11/2024 · Balance sheet for 30/11/2024 · Earnings statement for 30/11/2024
14 Jan 2025 also 18/06/2019, 10/05/2019, 07/05/2019, 06/05/2019, 20/12/2016, 14/11/2016, 21/03/2016, 21/03/2016, 29/02/2016, 29/02/2016, 02/02/2015, 10/10/2014, 21/01/2011, 11/10/2010, 18/07/2008, 14/01/2008, 15/12/2006, 22/11/2005
Articles of association
27 Aug 2024 also 22/08/2024
Modification filing of previously filed documents (corrective)
8 Jul 2024
Annual report for the year ending 30/11/2023 · Balance sheet for 30/11/2023 · Earnings statement for 30/11/2023
21 May 2024
Shareholder: Pfizer Holdings International Luxembourg (Phil) Sàrl · No longer Shareholder: Pfizer Pharmaceuticals B.V
16 May 2024
Shareholder: Pfizer Pharmaceuticals B.V. · No longer Shareholder: C.P. Pharmaceuticals International CV
14 May 2024
Shareholder: C.P. Pharmaceuticals International CV
10 May 2024
Shareholder: C.P. Pharmaceuticals International CV
6 May 2024 also 02/05/2024, 29/04/2024, 19/11/2018
Modification, Associate(s)
26 Apr 2024
Shareholder: C.P. Pharmaceuticals International CV · No longer Shareholder: Pfizer Pharmaceuticals Global B.V
23 Apr 2024
No longer Shareholder: Pfizer Holdings International Luxembourg (Phil) Sàrl
4 Dec 2023 via PF Prism Sàrl
Liquidator: PF Prism Sàrl
21 Nov 2023 via Pfizer Luxembourg Global Holdings Sàrl
Partner: Pfizer Luxembourg Global Holdings Sàrl
21 Jun 2023
Annual report for the year ending 30/11/2022 · Balance sheet for 30/11/2022 · Earnings statement for 30/11/2022
1 Dec 2022
Managing Director: Magali Koneczny
17 Jun 2022
Annual report for the year ending 30/11/2021 · Balance sheet for 30/11/2021 · Earnings statement for 30/11/2021
18 Mar 2022
Managing Director: J. Heiligenberg · No longer Managing Director: Johannes Hofs
18 Jun 2021
Annual report for the year ending 30/11/2020 · Balance sheet for 30/11/2020 · Earnings statement for 30/11/2020
25 Aug 2020
Annual report for the year ending 30/11/2019 · Balance sheet for 30/11/2019 · Earnings statement for 30/11/2019
15 Jul 2019
No longer Shareholder: Pfizer Shareholdings Intermediate Sàrl · Capital: $3.28B
9 Jul 2019 via Pfizer Luxembourg Global Holdings Sàrl
Partner: Pfizer Luxembourg Global Holdings Sàrl
4 Jul 2019
Shareholder: Pfizer Holdings International Luxembourg (Phil) Sàrl, Pfizer Shareholdings Intermediate Sàrl
27 Jun 2019
Annual report for the year ending 30/11/2018 · Balance sheet for 30/11/2018 · Earnings statement for 30/11/2018
19 Jun 2019 via Pfizer Luxembourg Global Holdings Sàrl
Partner: Pfizer Luxembourg Global Holdings Sàrl
27 May 2019
Shareholder: Pfizer Holdings International Luxembourg (Phil) Sàrl · Capital: $3.83B
10 May 2019
Managing Director: Réginald Decraene, Johannes Hofs · No longer Managing Director: S. Savarinayagam
11 Jan 2019
Modification, Merger/Demerger
4 Jan 2019 via Pfizer Luxembourg Global Holdings Sàrl
Partner: Pfizer Luxembourg Global Holdings Sàrl
Year 2018 in Rcsf
3 Shareholdings: Pfizer PFE Sweden Holding Sàrl, PF Prism Sàrl, PF Prism Holdings Sàrl · Partner: Pfizer Luxembourg Global Holdings Sàrl · Shareholding: PF Prism Holdings Sàrl
11 Dec 2018
Shareholder: Pfizer Holdings International Luxembourg (Phil) Sàrl · Capital: $3.82B
10 Dec 2018
Modification (corrective), Social capital/social funds
4 Dec 2018
Shareholder: Pfizer Holdings International Luxembourg (Phil) Sàrl · No longer Shareholder: Pfizer Shareholdings Intermediate Sàrl · Capital: $3.12B
26 Nov 2018
Shareholder: Pfizer Shareholdings Intermediate Sàrl
15 Nov 2018
Shareholder: Pfizer Holdings International Luxembourg (Phil) Sàrl · Capital: $3.10B
14 Nov 2018
Merger / demerger /professional property and staff transfer project
2 Jul 2018
Annual report for the year ending 30/11/2017 · Balance sheet for 30/11/2017 · Earnings statement for 30/11/2017
23 May 2018
Managing Director: Johannes Hofs, S. Savarinayagam · No longer Managing Director: Adrienn Marton, André Petrunoff
5 Dec 2017
No longer Managing Director: S. Savarinayagam
6 Jul 2017
Annual report for the year ending 30/11/2016 · Balance sheet for 30/11/2016 · Earnings statement for 30/11/2016
7 Apr 2017 via Pfizer Luxembourg Global Holdings Sàrl
Partner: Pfizer Luxembourg Global Holdings Sàrl
1 Dec 2016
Managing Director: S. Savarinayagam
26 Sept 2016
Shareholder: Pfizer Holdings International Luxembourg (Phil) Sàrl · Capital: $3.09B
12 Sept 2016 also 24/07/2015, 29/07/2014, 17/10/2013
Annual accounts (eCDF)
5 Sept 2016
Shareholder: Pfizer Holdings International Luxembourg (Phil) Sàrl · Capital: $3.09B
21 Mar 2016
Shareholder: Pfizer Holdings International Luxembourg (Phil) Sàrl · Capital: $3.00B
18 Mar 2016
Shareholder: Pfizer Holdings International Luxembourg (Phil) Sàrl · Capital: $2.89B
19 Jan 2016
Manager: Ch. Plantegenet
22 Dec 2015
Shareholder: Pfizer Holdings International Luxembourg (Phil) Sàrl · Capital: $2.65B
17 Dec 2015
Shareholder: Pfizer Holdings International Luxembourg (Phil) Sàrl · Capital: $2.46B
5 Aug 2015
Managing Director: Adrienn Marton · No longer Managing Director (1)
7 Jan 2015 via Pfizer PFE Ireland Holdco Sàrl
Shareholding: Pfizer PFE Ireland Holdco Sàrl
10 Dec 2014 via Pfizer PFE Luxembourg Holding 2 Sàrl
Shareholding: Pfizer PFE Luxembourg Holding 2 Sàrl
19 Nov 2014
Shareholder: Pfizer Holdings International Luxembourg (Phil) Sàrl · Capital: $2.31B
4 Nov 2013 also 16/05/2011, 18/04/2011, 20/01/2011, 20/08/2010, 28/12/2009, 18/07/2008, 20/06/2008, 07/05/2008, 14/01/2008, 12/12/2007, 12/04/2007, 15/12/2006, 12/09/2006, 09/02/2006, 08/02/2006, 29/11/2005, 15/11/2005, 09/02/2005
Modification
15 Mar 2013 also 08/07/2011, 20/08/2010, 13/08/2009, 01/07/2008, 16/07/2007, 09/10/2006, 05/08/2005
Annual accounts
17 Jun 2011
Modification (correction or additional)
16 Aug 2010
Annual accounts (correction)
18 Aug 2005
Historique reprise Notes
There are no publications matching your search.

Mentions

27 Mar 2026 in Ler
Direct parent
27 Mar 2026 in Ler
Ultimate parent
19 Mar 2026 in Ler
Direct parent: Pfizer Romania Srl
13 Apr 2025 in Ler
Direct parent: PF Finland Holdings B.V
7 Apr 2025 in Ler
Direct parent: PF Czech Republic Holdings B.V
23 Apr 2024 in Vr
Reg­is­tra­tion: 28/05/1993 · No longer Director (7) · Director (1) · No longer Director: John L.E. Seidler · Change of shareholdings (10 companies) · Capital: 154.9M CZK · Corporate Purpose
There are no publications matching your search.

The data on this page is generated by a fully automated algorithm. It may have errors, and is provided on an "as is" basis with no guarantees of completeness, accuracy, usefulness or timeliness.

Printing is only available to North Data premium service subscribers.